USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
15.27
+0.25 (1.66%)
At close: Sep 14, 2026, 4:00 PM EDT
15.27
0.00 (0.00%)
After-hours: Sep 14, 2026, 7:30 PM EDT
← View all transcripts

AGM 2026

May 20, 2026

Summary

Shareholders elected all director nominees, ratified KPMG as auditor, and approved executive compensation. Quorum was established at 89%, and no questions were raised before adjournment.

Kevin Guest
Chairman and CEO, USANA Health Sciences

Good morning. Welcome to this 2026 annual meeting of shareholders of USANA Health Sciences Incorporated. I'm Kevin Guest, Chairman and Chief Executive Officer. Before this meeting begins, I want to welcome you and express the appreciation of the Board of Directors and management for your attendance today.

In attendance today are members of the Board of Directors and management of the company and certain other guests, including representatives of KPMG, USANA's independent registered public accounting firm. We welcome our shareholders who are attending via the web for our virtual annual meeting.

Please note that all of this meeting is being recorded. No one attending via the webcast is permitted to use any audio recording device to record the meeting. As is our custom, we will conduct the business portion of our meeting first and answer questions at the end of the meeting.

Only validated shareholders may ask questions in the designated field on the web portal. I will now call the meeting to order. Notice of this annual meeting was mailed on or about April 7th, 2026 to each shareholder of record at the close of business on March 16th, 2026. As a copy of the notice of the annual meeting, proxy materials, and a shareholder list as of March 16th, 2026 are available for the shareholders' inspection through the web portal.

The board of directors has appointed P. Joshua Foukas to act as Inspector of Elections at this meeting. The Inspector has previously executed an oath of office and delivered it to the Secretary to be filed with the minutes of this meeting.

The inspector has made a poll of the shares represented at this meeting virtually or by proxy, and also received a report of the votes received by proxy prior to this meeting from Broadridge. I will now ask the inspector to report on the presence of quorum.

P. Joshua Foukas
Chief Legal Officer, General Counsel, and Corporate Secretary, USANA Health Sciences

Thanks, Kevin. I'm pleased to report that 89% of the issued and outstanding shares of the company are represented virtually or by proxy at the meeting today.

Kevin Guest
Chairman and CEO, USANA Health Sciences

Thank you, Joshua. Since the majority of the company's outstanding shares is represented here today, a quorum is present. The meeting is duly constituted, and the business of the meeting may proceed. We have three items of business on the agenda today. First, the election of the board of directors. Second is the ratification of the audit committee's election of KPMG as USANA's independent registered public accounting firm.

Third is a non-binding advisory vote to approve the company's executive compensation, commonly referred to as say on pay. The 1st item of business is the election of the board of directors. As noted in the proxy statement, the slate of directors standing for election includes the following persons: Kevin Guest, Xia Ding, John T. Fleming, Gilbert A. Fuller, J. Scott Nixon, Peggie Pelosi, Frederic J. Winssinger, and Dr. Timothy Wood. Biographical and professional experience details for these individuals are included in the proxy statement.

No other persons were nominated. Therefore, the nominations are closed. For the second item of business, the audit committee of the board of directors has selected KPMG as USANA's independent registered public accounting firm for the fiscal year 2026, and shareholders are being asked to ratify this selection. KPMG has served in this role since September 16th, 2013.

USANA's board of directors recommends that shareholders vote for the approval of the appointment of KPMG as USANA's independent registered public accounting firm. Finally, the last order of business is an advisory vote to approve the compensation of USANA's named executive officers, as disclosed in the executive compensation section of our proxy statement.

The board of directors recommends that you vote for the approval of our executive compensation. With that, the polls are now open.

Any shareholder who hasn't yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. Shareholders who have sent in proxies or voted via telephone or internet and do not want to change your vote do not need to take any further action.

Now that everyone has had the opportunity to vote, I now declare the polls for the 2026 USANA Health Sciences Annual Shareholder Meeting closed. I will now ask the Inspector of Elections to report the results of the balloting.

P. Joshua Foukas
Chief Legal Officer, General Counsel, and Corporate Secretary, USANA Health Sciences

I'm pleased to report that shareholders holding the required number of shares have elected each of the nominees for the board of directors, ratified the selection of KPMG as USANA's independent registered public accounting firm, and voted for the approval of our executive compensation.

Kevin Guest
Chairman and CEO, USANA Health Sciences

Thank you, Joshua. We will publish the exact voting results in a Form 8-K that will be filed with the SEC and made available on USANA's website following this meeting. That concludes the business of the annual meeting. We will now open the floor for questions. As there are no questions, this annual meeting is adjourned.

Operator

This now concludes the meeting. Thank you for joining, and have a pleasant day.